Technology and Data

Pharmacy and AI expert Timothy Aungst, PharmD, joins Drug Topics to provide an in-depth look at AI’s evolution in pharmacy practice today.

Rick Couldry, MS/HSPA, discusses how cloud-native software resolves fragmented systems, improves tracking, and streamlines clinical workflows.

In part 2, Rick Couldry, MS/HSPA, provides necessary nuance to the value driving cloud-based medication management to the forefront of health care.

Researchers aim to better understand the perspectives of providers amid ongoing transformations.

Managing diabetes has shifted from reactive monitoring to a proactive, technology-driven standard of care that emphasizes real-time data and personalized treatment.

New policies urge pharmacists to identify disinformation and seek legal protection against AI-generated impersonation.

Through the lens of pharmacist satisfaction, researchers assess the implementation and real-world use of medication alert systems.

Researchers assess how these emerging platforms can support medication use across this patient population.

Among US adults with and without chronic medical conditions, researchers examine social media use for health-related information.

Through a secret shopper study, researchers assessed the process for obtaining GLP-1 therapy via the internet and the clinical engagement associated with the purchase.

Machine learning can uncover immune responses to conserved pneumococcal protein antigens.

Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

In part 2 of our interview with Julia Vu, PharmD, she delves into the AI space within pharmacy practice while touching on the industry’s role in boosting rural health outcomes.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

Despite a myriad of data and news releases about the growing prominence of AI in pharmacy practice, several knowledge and acceptance gaps persist.

As artificial intelligence becomes commonplace in medical practice, officials are gradually uncovering significant safety risks.

With its capabilities improving rapidly in the health care space, technology and pharmacy experts discuss AI’s future place in pharmacy practice as further developments are released.

An exploration of community pharmacists’ perceptions of e-pharmacy, assessing whether they believe it’s a threat or benefit.

Researchers conduct an exploration of e-prescription challenges and potential across pharmacies in Germany.

Amid increased use of artificial intelligence across pharmacy, researchers assess pharmacists’ propensity to trust the emerging automated technology.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

As the pharmacy industry seemingly transforms in real-time, expert pharmacists and digital health experts explain how DTP models are paving a new path for drug distribution.